skip to Main Content

SPEAKERS

SAMPLE OF KEYNOTE SPEAKERS AND THEIR CASE STUDIES

Penny
ALLINSON

Associate Director, Patient Recruitment Programs

CASE STUDY / DAY 1

Combining Patient Engagement and Transparency in Clinical Development

Successful patient recruitment and retention is only possible when you truly understand your patient population; when you view the protocol from the patient’s perspective. During this presentation we will focus on a paediatric rare disease case study and explore how Pfizer has been working in close collaboration with patients to bring their voice into the design, planning and execution of the study and its associated recruitment/retention activities.

  • Paediatric rare disease case study
  • Successful patient recruitment and retention planning
  • Establishing early patient and caregiver engagement regarding protocol design
  • Collaborating with patient groups to gain insights into operational plans and recruitment/retention activities
  • Conducting paediatric protocol simulations to understand trial burden
  • Continuing close engagement and collaboration with patient communities throughout the study duration

CASE STUDY / DAY 1

Virtual External Meetings

One of the known tools for fueling recruitment and retention is focused interaction with site staff during trial conduct. Here large mid-study investigator meetings can be an option. Investigator meetings, presenting trial results, can also positively affect site recruitment for future trials. However, face to face meetings are time consuming and costly.  An alternative way to achieve these goals is via virtual meetings. They enable multiple participants to join without increased cost and introduce a huge flexibility in meeting time and place. In this presentation different types of virtual meetings – as well as learnings – will be shared of how to conduct a virtual investigator/results meeting.

  • Recruitment and Retention
  • Retaining sites for future trials
  • Virtual meetings – what are the options?
  • Pro’s and con’s
  • Learnings and practical tips

Birgitte
CLAUDIUS

MD, Director, Head Clinical Operations

This year Summit will host speakers from the world’s leading companies.
See sample of key note speakers.

Barbara
VALASTRO

Clinical Program Director

Pascale
CAVILLON

Global Patient Centricity Director

Birgitte
CLAUDIUS

MD, Director, Head Clinical Operations

Richard
STEPHENS

Patient Advocate

Penny
ALLINSON

Associate Director, Patient Recruitment Programs

Belle
ROELS

Head of Clinical Operations UK and Ireland

CASE STUDY / DAY 2

Making the Most of Real-World Evidence: Listen and Learn from Patients

By definition, Non- Interventional Studies (NIS) should be less burdensome then interventional study for patients. Nonetheless, patient’s experience on participating to NIS is still to be improved from the consent form signature up to the study end experience. These studies are also great opportunity to learn more from patients and to shape real medical practice with patients for patients to improve their quality of life. This is a well-understood strategic objective of the ClinOPs medical affairs team that started their transition to more patient-centric program. Our case study will share the goal of one NIS that is not only to gather information from a real-life cohort, it also aims at a better understanding of disease management impact on patients’ quality of life, assessed through patient and physician questionnaire. A subsequent patient workshop was planned to ensure the collection of patients’ advices on materials needed to help study patients and future patients understand the questionnaire setting concept and process. We propose to share with you the setup of this workshop from patient engagement up to the concrete deliverables further to the patient workshop.

  • Patient centricity at Ipsen: work for patients with patients to help improve patient outcomes
  • Patient centricity as a mindset and process
  • Real-world study and patient engagement
  • Listening and co-creation with patients on supporting tools
  • Patient workshop setup, conduct and lessons learned

Pascale
CAVILLON

Global Patient Centricity Director

Jean-Charles
DHUIN

Head of GMA Clinical Operations

Barbara
VALASTRO

Clinical Program Director

Evelina
BJÖRNSSON

Director Study Management

CASE STUDY / DAY 2

Hybrid Virtual Trials – Innovative Design and Lessons Learned

Virtual trials are gaining popularity in the pharmaceutical world and AstraZeneca is evaluating this innovative approach for the benefit of patients and to improve recruitment/retention in clinical trials. During this session, we will share with the attendees some of our recent learnings from a paediatric study.

  • Hybrid Virtual Trial
  • Paediatric
  • Lessons learned
FOR MORE INFORMATION REQUEST FULL PROGRAMME

See what keynote speakers will be taking part in the exclusive speaking panel.
Explore what Case Studies will be discussed by our senior corporate speakers

12th Annual Patient Recruitment and Retention Summit
TIME IS RUNNING OUT! DON’T RISK MISSING IT

THANK YOU FOR YOUR CALL REQUEST

You will be contacted shortly.

Back To Top

RELATED EVENTS

9th Annual Pharma Marketing - Digital Marketing & CEM
9th Annual Pharma Commercial & SFE Summit
13th Annual Optimising Clinical Trials Site Selection & Feasibility Summit
6th Annual Risk Management and Pharmacovigilance Summit